Intellipharmaceutics International Inc. (Nasdaq: IPCI) announced that it has entered into a license and commercial supply agreement with Mallinckrodt LLC ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE